KERALA AYURVEDA
Quarterly Results Analysis [Dec2023]
KERALA AYURVEDA Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 Audited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
Sep2022 Audited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹26 Cr | ₹26 Cr | ₹24 Cr | ₹24 Cr | ₹23 Cr | ₹24 Cr | ₹19 Cr | ₹21 Cr |
Expenses | ₹25 Cr | ₹26 Cr | ₹22 Cr | ₹23 Cr | ₹25 Cr | ₹22 Cr | ₹18 Cr | ₹19 Cr |
Operating Income | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹-2 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr |
Other Income | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Interest | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr |
Depreciation | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Profit Before Tax | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹0 Cr | ₹1 Cr | ₹-1 Cr | ₹0 Cr |
Profit After Tax | ₹-1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹1 Cr | ₹-1 Cr | ₹0 Cr |
EPS | ₹-0.71 | ₹-0.12 | ₹-0.34 | ₹0.17 | ₹-1.04 | ₹0.98 | ₹-0.85 | ₹-0.03 |
Industry Peers & Returns | 1W | 1M | 1Y |
KERALA AYURVEDA | 4% | 15.5% | 177.6% |
SUN PHARMACEUTICAL INDUSTRIES | -2.3% | -6.5% | 55.3% |
CIPLA | 4.1% | -4.8% | 55.6% |
DR REDDYS LABORATORIES | 4% | 0.8% | 29.4% |
ZYDUS LIFESCIENCES | -1.2% | -5.2% | 83.9% |
DIVIS LABORATORIES | 7.8% | 17.4% | 20.3% |
MANKIND PHARMA | 1.3% | 7% | NA |
TORRENT PHARMACEUTICALS | 3.9% | 5.1% | 66.1% |
LUPIN | 0.6% | 0.5% | 127.2% |
KERALA AYURVEDA Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 0.58 % |
Y-o-Y | 12.80 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹26 Cr | 0.58 | |
Sep2023 | ₹26 Cr | 10.03 | |
Jun2023 | ₹24 Cr | -0.26 | |
Mar2023 | ₹24 Cr | 2.19 | |
Dec2022 | ₹23 Cr | -2.59 | |
Sep2022 | ₹24 Cr | 25.48 | |
Jun2022 | ₹19 Cr | -8.23 | |
Mar2022 | ₹21 Cr | - |
KERALA AYURVEDA Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 87.73 % |
Y-o-Y | Positive |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹1 Cr | 87.73 | |
Sep2023 | ₹1 Cr | -64.93 | |
Jun2023 | ₹2 Cr | 120.72 | |
Mar2023 | ₹1 Cr | Positive | |
Dec2022 | ₹-2 Cr | Negative | |
Sep2022 | ₹2 Cr | 238.02 | |
Jun2022 | ₹1 Cr | -68.85 | |
Mar2022 | ₹2 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 86.41 % |
Y-o-Y | Positive |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 3.84% | 86.41 | |
Sep2023 | 2.06% | -68.06 | |
Jun2023 | 6.45% | 120.89 | |
Mar2023 | 2.92% | Positive | |
Dec2022 | -6.85% | Negative | |
Sep2022 | 9.24% | 169.39 | |
Jun2022 | 3.43% | -66.07 | |
Mar2022 | 10.11% | - |
KERALA AYURVEDA Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹-1 Cr | Negative | |
Sep2023 | ₹0 Cr | Positive | |
Jun2023 | ₹0 Cr | Negative | |
Mar2023 | ₹0 Cr | Positive | |
Dec2022 | ₹-1 Cr | Negative | |
Sep2022 | ₹1 Cr | Positive | |
Jun2022 | ₹-1 Cr | Negative | |
Mar2022 | ₹0 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | -3.01 % | Negative | |
Sep2023 | 0.01 % | Positive | |
Jun2023 | -1.27 % | Negative | |
Mar2023 | 1.99 % | Positive | |
Dec2022 | -4.72 % | Negative | |
Sep2022 | 4.25 % | Positive | |
Jun2022 | -4.28 % | Negative | |
Mar2022 | 0.02 % | - |
KERALA AYURVEDA Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹-0.71 | Negative | |
Sep2023 | ₹-0.12 | Negative | |
Jun2023 | ₹-0.34 | Negative | |
Mar2023 | ₹0.17 | Positive | |
Dec2022 | ₹-1.04 | Negative | |
Sep2022 | ₹0.98 | Positive | |
Jun2022 | ₹-0.85 | Negative | |
Mar2022 | ₹-0.03 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD